BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Natali A, Nesti L, Tricò D, Ferrannini E. Effects of GLP-1 receptor agonists and SGLT-2 inhibitors on cardiac structure and function: a narrative review of clinical evidence. Cardiovasc Diabetol 2021;20:196. [PMID: 34583699 DOI: 10.1186/s12933-021-01385-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Zhong Y, Zhang Z, Yang S, Zhang Q, Chu B, Hu X. Effect of sodium-glucose cotransporter protein-2 inhibitors on left ventricular hypertrophy in patients with type 2 diabetes: A systematic review and meta-analysis. Front Endocrinol (Lausanne) 2022;13:1088820. [PMID: 36699027 DOI: 10.3389/fendo.2022.1088820] [Reference Citation Analysis]
2 Nesti L, Pugliese NR, Chiriacò M, Trico D, Baldi S, Natali A. Epicardial adipose tissue thickness is associated with reduced peak oxygen consumption and systolic reserve in patients with type 2 diabetes and normal heart function. Diabetes Obes Metab 2023;25:177-88. [PMID: 36066008 DOI: 10.1111/dom.14861] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
3 Bertacchini F, Agabiti Rosei C, Buso G, Cappellini S, Stassaldi D, Aggiusti C, Salvetti M, Paini A, De Ciuceis C, Muiesan ML. Subclinical HMOD in Hypertension: Left Ventricular Diastolic Dysfunction. High Blood Press Cardiovasc Prev 2022. [DOI: 10.1007/s40292-022-00548-z] [Reference Citation Analysis]
4 Baviera M, Foresta A, Colacioppo P, Macaluso G, Roncaglioni MC, Tettamanti M, Fortino I, Genovese S, Caruso I, Giorgino F. Effectiveness and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in type 2 diabetes: an Italian cohort study. Cardiovasc Diabetol 2022;21:162. [PMID: 35999556 DOI: 10.1186/s12933-022-01572-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Madsbad S, Holst JJ. Cardiovascular effects of incretins - focus on GLP-1 receptor agonists. Cardiovasc Res 2022:cvac112. [PMID: 35925683 DOI: 10.1093/cvr/cvac112] [Reference Citation Analysis]
6 Patoulias D, Boulmpou A, Doumas M, Papadopoulos CE. Another brick in the wall of cardioprotection? A meta-analysis addressing the effect of sodium-glucose co-transporter 2 inhibitors on left ventricular mass assessed by cardiovascular magnetic resonance in patients with heart failure with reduced ejection fraction. J Cardiovasc Med (Hagerstown) 2022;23:570-2. [PMID: 35905005 DOI: 10.2459/JCM.0000000000001328] [Reference Citation Analysis]
7 Wong SY, Lee ARYB, Sia AHJ, Wo YJ, Teo YH, Teo YN, Syn NL, Ong CC, Teo LL, Yeo TC, Poh KK, Kong WK, Wong RC, Sia CH. Effects of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) on Cardiac Structure and Function: A Systematic Review and Meta-Analysis of Randomized-Controlled Trials. Cardiovasc Drugs Ther 2022. [PMID: 35819544 DOI: 10.1007/s10557-022-07360-w] [Reference Citation Analysis]
8 Turan B, Durak A, Olgar Y, Tuncay E. Comparisons of pleiotropic effects of SGLT2 inhibition and GLP-1 agonism on cardiac glucose intolerance in heart dysfunction. Mol Cell Biochem. [DOI: 10.1007/s11010-022-04474-5] [Reference Citation Analysis]
9 Teo YN, Ting AZH, Teo YH, Chong EY, Tan JTA, Syn NL, Chia AZQ, Ong HT, Cheong AJY, Li TY, Poh KK, Yeo TC, Chan MY, Wong RCC, Chai P, Sia CH. Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors and Combined SGLT1/2 Inhibitors on Cardiovascular, Metabolic, Renal, and Safety Outcomes in Patients with Diabetes: A Network Meta-Analysis of 111 Randomized Controlled Trials. Am J Cardiovasc Drugs 2022;22:299-323. [PMID: 35316484 DOI: 10.1007/s40256-022-00528-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
10 Xu J, Hirai T, Koya D, Kitada M. Effects of SGLT2 Inhibitors on Atherosclerosis: Lessons from Cardiovascular Clinical Outcomes in Type 2 Diabetic Patients and Basic Researches. J Clin Med 2021;11:137. [PMID: 35011882 DOI: 10.3390/jcm11010137] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]